| Jul'19 | Jul'18 | Jul'17 | Jul'16 | Jul'15 | Jul'14 | Jul'13 | Jul'12 | Jul'11 | Jul'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||
Net (loss) income | |||||||||
55,042 | 91,041 | 71,378 | 59,953 | 47,953 | 43,265 | 39,239 | 31,337 | 20,425 | 19,941 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
Depreciation | |||||||||
21,510 | 17,473 | 15,045 | 11,989 | 10,692 | 8,245 | 7,202 | 6,801 | 6,759 | 6,333 |
Amortization | |||||||||
20,849 | 17,357 | 18,407 | 13,095 | 13,265 | 10,641 | 10,061 | 9,124 | 5,687 | 5,105 |
Stock-based compensation expense | |||||||||
15,562 | 9,615 | 8,844 | 8,361 | 5,867 | 5,409 | 3,733 | 3,840 | 3,350 | 3,130 |
Impairment of convertible notes receivable | |||||||||
- | - | - | - | - | - | - | 605 | - | - |
Deferred income taxes | |||||||||
-2,062 | -7,520 | 118 | -1,710 | -1,449 | -1,218 | -368 | 370 | -1,799 | -2,221 |
Amortization of debt issuance costs | |||||||||
- | - | - | - | 401 | 440 | 345 | 373 | 321 | 470 |
Loss on disposal of fixed assets | |||||||||
- | - | - | - | -360 | -501 | -184 | -105 | -10 | -238 |
Loss on sale of business | |||||||||
- | - | - | - | -2,206 | - | - | - | - | - |
Impairment of assets | |||||||||
- | - | - | - | 1,287 | - | - | - | - | - |
Fair value adjustments to contingent consideration | |||||||||
- | - | - | - | -2,585 | 219 | -2,492 | - | - | - |
Excess tax benefits from stock-based compensation | |||||||||
- | - | - | 1,179 | 3,168 | 4,391 | 2,875 | 1,970 | 776 | 424 |
Other non-cash items, net | |||||||||
1,940 | -1,076 | -1,102 | -267 | - | - | - | - | - | - |
Changes in assets and liabilities, net of effects of acquisitions/dispositions: | |||||||||
Accounts receivable | |||||||||
23,048 | 3,700 | 12,860 | 12,729 | 3,905 | 6,149 | 2,447 | -2,307 | 13,449 | 1,065 |
Inventories | |||||||||
28,711 | 3,785 | -887 | 15,558 | 10,075 | 2,658 | 5,262 | 2,227 | 2,038 | 5,189 |
Prepaid expenses and other assets | |||||||||
2,364 | 5,169 | 957 | 2,850 | 2,996 | 2,388 | 1,387 | 345 | 418 | -436 |
Accounts payable and other liabilities | |||||||||
13,325 | 10,614 | 7,124 | 17,657 | -3,347 | 6,205 | 931 | -177 | 7,266 | 1,272 |
Income taxes | |||||||||
-1,232 | -1,090 | -895 | 2,972 | 4,564 | 6,151 | 4,630 | 437 | 2,860 | 1,007 |
Other assets and liabilities | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Net cash provided by operating activities | |||||||||
66,931 | 125,912 | 108,193 | 80,268 | 59,070 | 64,272 | 51,494 | 50,580 | 28,198 | 29,033 |
Capital expenditures | |||||||||
95,438 | 37,698 | 27,065 | 18,889 | 12,760 | 13,541 | 6,745 | 5,502 | 5,835 | 5,605 |
Proceeds from disposal of fixed assets | |||||||||
0 | 0 | 47 | 96 | 25 | 14 | 32 | 9 | 78 | 5 |
Proceeds from sale of businesses | |||||||||
3,053 | 0 | 0 | - | 3,767 | - | - | - | - | - |
Acquisition of Sterilator, net of cash acquired | |||||||||
- | - | - | - | - | - | - | 95,261 | - | - |
Acquisitions, net of cash acquired | |||||||||
40,644 | 87,488 | 70,044 | 94,528 | 43,567 | 33,547 | - | 1,550 | 22,150 | - |
Acquisition of Siemens Water | |||||||||
- | - | - | - | - | - | 8,300 | - | 7,500 | - |
Acquisition of Eagle Pure Water | |||||||||
- | - | - | - | - | - | 870 | - | - | - |
Acquisition of Polyp Trap | |||||||||
- | - | - | - | - | - | 486 | - | - | -1,970 |
Acquisition of SPS, net of cash acquired | |||||||||
- | - | - | - | - | - | 35,415 | 855 | - | - |
Acquisition of Twist | |||||||||
- | - | - | - | - | - | - | - | - | 157 |
Purchase of convertible notes receivable | |||||||||
- | - | - | - | - | - | - | - | - | 300 |
Other, net | |||||||||
- | - | - | -339 | -241 | 358 | 262 | -44 | 314 | 213 |
Net cash used in investing activities | |||||||||
-133,029 | -125,186 | -97,062 | -112,982 | -52,294 | -47,432 | -52,046 | -103,115 | -35,721 | -8,240 |
Borrowings of long-term debt | |||||||||
0 | 200,000 | 0 | 0 | - | - | - | 49,647 | - | - |
Repayments of long-term debt | |||||||||
15,207 | 0 | 0 | - | - | - | - | - | - | - |
Borrowings under revolving credit facility | |||||||||
50,000 | 82,300 | 74,000 | 96,500 | 47,000 | 28,000 | 45,000 | 46,941 | 28,000 | - |
Repayments under term loan facility | |||||||||
- | - | - | - | - | 5,000 | 10,000 | 10,000 | 10,000 | 10,000 |
Repayments under revolving credit facility | |||||||||
7,000 | 208,300 | 64,000 | 59,000 | 49,000 | 37,500 | 30,000 | 22,000 | 15,000 | 12,300 |
Debt modification costs | |||||||||
- | - | - | - | - | 1,314 | - | - | - | - |
Proceeds from exercises of stock options | |||||||||
- | - | - | - | 608 | 634 | 1,817 | 2,372 | 2,555 | 2,139 |
Dividends paid | |||||||||
8,350 | 7,091 | 5,841 | 5,005 | 4,154 | 3,721 | 3,016 | 2,523 | 2,064 | 1,683 |
Debt issuance costs | |||||||||
0 | 2,698 | 0 | 0 | - | - | - | - | - | - |
Excess tax benefits from stock-based compensation | |||||||||
- | - | - | 1,179 | 3,168 | 4,391 | 2,875 | 1,970 | 776 | 424 |
Purchases of treasury stock | |||||||||
4,741 | 7,074 | 6,910 | 3,732 | 3,727 | 4,439 | 2,252 | 1,904 | 1,290 | 426 |
Net cash provided by financing activities | |||||||||
14,702 | 57,137 | -2,751 | 29,942 | -6,105 | -18,949 | 4,424 | 64,503 | 2,977 | -21,846 |
Effect of exchange rate changes on cash and cash equivalents | |||||||||
1,834 | -350 | -163 | -581 | -732 | -186 | 18 | -192 | 344 | 297 |
Increase (decrease) in cash and cash equivalents | |||||||||
-49,562 | 57,513 | 8,217 | -3,353 | -61 | -2,295 | 3,890 | 11,776 | -4,202 | -756 |
Cash interest payments | |||||||||
9,296 | 5,156 | 3,455 | 3,001 | 1,970 | - | - | - | - | - |
Cash income tax payments | |||||||||
19,024 | 35,251 | 35,858 | 33,559 | 25,239 | - | - | - | - | - |
Accruals related to purchases of property and equipment | |||||||||
3,311 | 2,281 | 192 | 0 | - | - | - | - | - | - |